Akorn, Fera, Perrigo Settle Trade Secrets, Antitrust Suit

Law360, New York (January 30, 2018, 3:13 PM EST) -- Fera Pharmaceuticals LLC and Akorn Inc. have settled a $100 million trade secrets case tied to a supply agreement for eye infection treatments, along with antitrust counterclaims that brought Perrigo Co. PLC into the mix, ending the suit Monday, just weeks before a scheduled trial.

Perrigo attorney Christopher W. Healy of Reed Smith LLP sent a letter to the New York federal court Saturday asking for the Feb. 20 trial date to be canceled given the settlement, which he said they're still finalizing. Senior U.S. District Judge Louis L. Stanton signed off on the request Monday.

"The parties have reached an...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Government Agencies

Judge Analytics

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!